You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
欧药管局官员称阿斯利康疫苗与血栓塞有关 儿童及青少年临床测试已暂停
阿思达克 04-07 08:25
欧洲药品管理局疫苗策略主管卡瓦莱里表示,相信阿斯利康(AZN.US)新冠疫苗与血栓塞个案有关,该局准备好在本周发表更明确的声明。

他称,暂时未知导致出现血栓塞的原因,将继续重点调查有较多年轻接种者出现脑血栓塞的成因,不过强调疫苗仍然得到正面评价。

阿斯利康未有回应事件,但宣布暂停与牛津大学针对6至17岁儿童及青少年接种阿斯利康疫苗的研究。

世界卫生组织(WTO)表示,最快今日更新阿斯利康新冠疫苗的评估,但未有足够证据显示需要改变疫苗的利益及风险评估。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account